Torrent Pharmaceuticals Limited (TORNTPHARM.NS)
INR 3233.55
(-1.61%)
INR 3233.55
(-1.61%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 150.61 Billion INR | 0.33% |
| 2022 | 150.12 Billion INR | 14.6% |
| 2021 | 130.99 Billion INR | -6.93% |
| 2020 | 140.74 Billion INR | 0.26% |
| 2019 | 140.37 Billion INR | -0.59% |
| 2018 | 141.2 Billion INR | -0.86% |
| 2017 | 142.43 Billion INR | 40.67% |
| 2016 | 101.24 Billion INR | 12.33% |
| 2015 | 90.13 Billion INR | 13.94% |
| 2014 | 79.11 Billion INR | 56.04% |
| 2013 | 50.69 Billion INR | 34.02% |
| 2012 | 37.82 Billion INR | 23.08% |
| 2011 | 30.73 Billion INR | 20.61% |
| 2010 | 25.48 Billion INR | 29.68% |
| 2009 | 19.65 Billion INR | 17.85% |
| 2008 | 16.67 Billion INR | 31.73% |
| 2007 | 12.65 Billion INR | 21.14% |
| 2006 | 10.44 Billion INR | 10.94% |
| 2005 | 9.41 Billion INR | 32.54% |
| 2004 | 7.1 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 150.88 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 150.61 Billion INR | 0.33% |
| 2023 Q2 | 147.44 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 150.61 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 132.19 Billion INR | 0.0% |
| 2022 FY | 150.12 Billion INR | 14.6% |
| 2022 Q4 | 150.12 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 130.99 Billion INR | 0.0% |
| 2021 Q2 | 136.83 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 130.99 Billion INR | -6.93% |
| 2020 Q2 | 144.72 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 140.74 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 140.74 Billion INR | 0.26% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 139.76 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 140.37 Billion INR | -0.59% |
| 2019 Q4 | 140.37 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 141.2 Billion INR | -0.86% |
| 2018 Q4 | 141.2 Billion INR | 0.0% |
| 2018 Q2 | 150.51 Billion INR | 0.0% |
| 2017 FY | 142.43 Billion INR | 40.67% |
| 2017 Q4 | 142.43 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 100.49 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 101.24 Billion INR | 12.33% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 101.9 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 101.24 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 90.13 Billion INR | 13.94% |
| 2015 Q4 | 90.13 Billion INR | 0.0% |
| 2015 Q2 | 95.18 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2014 Q2 | 72.11 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 79.11 Billion INR | 56.04% |
| 2014 Q4 | 79.11 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 45.29 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 50.69 Billion INR | 0.0% |
| 2013 FY | 50.69 Billion INR | 34.02% |
| 2012 Q4 | 37.82 Billion INR | 0.0% |
| 2012 FY | 37.82 Billion INR | 23.08% |
| 2012 Q3 | - INR | 0.0% |
| 2011 FY | 30.73 Billion INR | 20.61% |
| 2011 Q4 | 30.73 Billion INR | 0.0% |
| 2010 FY | 25.48 Billion INR | 29.68% |
| 2009 FY | 19.65 Billion INR | 17.85% |
| 2008 FY | 16.67 Billion INR | 31.73% |
| 2007 FY | 12.65 Billion INR | 21.14% |
| 2006 FY | 10.44 Billion INR | 10.94% |
| 2005 FY | 9.41 Billion INR | 32.54% |
| 2004 FY | 7.1 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -133.664% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -10098.291% |
| FDC Limited | 24.68 Billion INR | -510.229% |
| Gufic Biosciences Limited | 10.92 Billion INR | -1278.529% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -30.415% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -587.385% |
| Orchid Pharma Limited | 15.53 Billion INR | -869.255% |
| Alkem Laboratories Limited | 155.74 Billion INR | 3.3% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -1868.43% |
| Brooks Laboratories Limited | 904.45 Million INR | -16552.035% |
| Eris Lifesciences Limited | 70.48 Billion INR | -113.666% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -428.38% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -541.822% |
| Innova Captab Limited | 13.2 Billion INR | -1040.224% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -6838.059% |
| Wanbury Limited | 3.43 Billion INR | -4284.659% |
| Lupin Limited | 239.97 Billion INR | 37.238% |
| Aarti Drugs Limited | 24.32 Billion INR | -519.193% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -483.285% |
| Albert David Limited | 4.97 Billion INR | -2924.349% |
| Alembic Limited | 23.28 Billion INR | -546.736% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -31888.395% |
| Hester Biosciences Limited | 6.62 Billion INR | -2173.884% |
| Hikal Limited | 24.87 Billion INR | -505.555% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -1192.672% |
| Ind-Swift Limited | 6.54 Billion INR | -2201.247% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -571.048% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -6173.806% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -2050.679% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -4417.069% |
| Medico Remedies Limited | 961.95 Million INR | -15556.69% |
| Morepen Laboratories Limited | 12.93 Billion INR | -1064.626% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -1795.992% |
| RPG Life Sciences Limited | 5.12 Billion INR | -2836.612% |
| Sigachi Industries Limited | 6.94 Billion INR | -2069.684% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 82.377% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -568.164% |
| Themis Medicare Limited | 5.66 Billion INR | -2558.997% |
| Unichem Laboratories Limited | 31.69 Billion INR | -375.209% |
| Vaishali Pharma Limited | 799.55 Million INR | -18736.681% |
| Venus Remedies Limited | 6.26 Billion INR | -2302.725% |
| Windlas Biotech Limited | 6.26 Billion INR | -2305.119% |
| ZIM Laboratories Limited | 4.46 Billion INR | -3270.691% |
| Sakar Healthcare Limited | 3.88 Billion INR | -3775.118% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 66.584% |
| Divi's Laboratories Limited | 154.7 Billion INR | 2.644% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -1297.088% |
| Mankind Pharma Limited | 119.63 Billion INR | -25.894% |
| Sequent Scientific Limited | 15.4 Billion INR | -877.743% |
| Laurus Labs Limited | 83.87 Billion INR | -79.575% |
| Neuland Laboratories Limited | 18.32 Billion INR | -721.855% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -277.078% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | -4.892% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 48.564% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -4005.261% |
| Wockhardt Limited | 76.49 Billion INR | -96.902% |
| Bal Pharma Limited | 3.2 Billion INR | -4600.848% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 61.135% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -1140.744% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -14722.2% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -458.357% |
| Shilpa Medicare Limited | 30.93 Billion INR | -386.906% |
| Valiant Laboratories Limited | 3.42 Billion INR | -4294.969% |
| Ajanta Pharma Limited | 46.38 Billion INR | -224.703% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -4838.16% |
| Granules India Limited | 55.2 Billion INR | -172.796% |
| Medicamen Biotech Limited | 2.94 Billion INR | -5013.703% |
| Ipca Laboratories Limited | 111.01 Billion INR | -35.669% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -3621.854% |
| Piramal Enterprises Limited | 826.05 Billion INR | 81.767% |
| NATCO Pharma Limited | 69.06 Billion INR | -118.076% |
| Suven Life Sciences Limited | 2.84 Billion INR | -5186.366% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -8352.94% |
| Strides Pharma Science Limited | 58.39 Billion INR | -157.905% |
| Indoco Remedies Limited | 21.44 Billion INR | -602.233% |
| Alpa Laboratories Limited | 1.82 Billion INR | -8147.103% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -9882.853% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -2824.239% |